GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $575,096 | -61.0% | 11,583 | -53.2% | 0.00% | -66.7% |
Q2 2023 | $1,472,901 | -0.7% | 24,738 | -5.6% | 0.01% | -14.3% |
Q1 2023 | $1,483,630 | +41.5% | 26,194 | +85.6% | 0.01% | +40.0% |
Q4 2022 | $1,048,173 | -32.9% | 14,113 | -46.2% | 0.01% | -44.4% |
Q3 2022 | $1,562,000 | -15.4% | 26,225 | -20.3% | 0.01% | -10.0% |
Q2 2022 | $1,847,000 | -22.6% | 32,891 | +1.7% | 0.01% | -16.7% |
Q1 2022 | $2,386,000 | -8.8% | 32,334 | -10.7% | 0.01% | +9.1% |
Q4 2021 | $2,615,000 | +66.7% | 36,214 | +76.8% | 0.01% | +57.1% |
Q3 2021 | $1,569,000 | +28.3% | 20,484 | +3.3% | 0.01% | +16.7% |
Q1 2021 | $1,223,000 | -25.2% | 19,827 | -20.9% | 0.01% | -25.0% |
Q4 2020 | $1,634,000 | -27.2% | 25,054 | -44.8% | 0.01% | -38.5% |
Q3 2020 | $2,246,000 | -2.3% | 45,363 | -5.9% | 0.01% | -7.1% |
Q2 2020 | $2,299,000 | -37.8% | 48,182 | -44.6% | 0.01% | -48.1% |
Q1 2020 | $3,698,000 | +83.7% | 86,957 | +154.4% | 0.03% | +125.0% |
Q4 2019 | $2,013,000 | – | 34,182 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |